Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276

od Schmidt, J, Braggio, E, Kortuem, KM, Egan, JB, Zhu, YX, Xin, CS, Tiedemann, RE, Palmer, SE, Garbitt, VM, McCauley, D, Kauffman, M, Shacham, S, Chesi, M, Bergsagel, PL, Stewart, AK
Izdano 2013

Genetic aberrations and survival in plasma cell leukemia

od Tiedemann, RE, Gonzalez-Paz, N, Kyle, RA, Santana-Davila, R, Price-Troska, T, Van Wier, SA, Chng, WJ, Ketterling, RP, Gertz, MA, Henderson, K, Greipp, PR, Dispenzieri, A, Lacy, MQ, Rajkumar, SV, Bergsagel, PL, Stewart, AK, Fonseca, R
Izdano 2008